Amit Mehta
General Partner @ Builders VC
Amit Mehta is a seed investor at Builders VC focused on Coffee and Health Care. Dr. Amit Mehta leads our health-IT investment practice. As a highly-regarded practicing professional, Amit combines practical knowledge across the value-chain with entrepreneurial experience to help companies from seed through Series B. Amit manages our investments into Carbon Health, Notable Labs and Fitbiomics, in addition to driving our overallHealth IT strategy. Prior to Builders, he was instrumental in deploying investments for Formation 8 in the health sector. His primary interest focusses on helping Builders' founders in market fit and establishing partnerships with hospital systems, clinics and ICNs. He is deeply interested in market validation of new technologies as well as successful strategies in go-to-market launches. Dr. Mehta completed his residency in Diagnostic Radiology at Harvard Medical School where he also completed a fellowship in Minimally Invasive Image Guided Surgery. He is a founder and the Chief Medical Officer at Intrinsic Imaging, a leading Healthcare IT company operating clinical trials in 64 countries globally for both pharma and biotech sponsors. He has co-authored three textbooks in Radiology, has widely published in peer-reviewed journals and currently is appointed as an SBIR/STTR reviewer for the National Institutes of Health. In addition to his clinical and operational pursuits, Amit serves on the boards of various start-ups and enjoys assisting entrepreneurs in launching early stage companies. He has been selected as one of the “Top 40 under 40″ by the San Antonio Business Journal.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Amit Mehta invests in
Stages Amit Mehta invests in
Countries Amit Mehta invests in
Investment Focus
Industry
- Coffee 1 (50%)
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Country
- India 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Arpeggio Bio
|
Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work. | $17M / Series A / Sep 07, 2022 | |
The Betel Leaf Co.
|
The Betel Leaf Co. is India’s first FSSAI Approved Online Paan delivery company. It's aim is to redefine the age-old tradition of the great Indian Dessert- Paan. With 45 different Flavours, its Paan & Betel Bars make for a perfect post- meal craving solution. | $800K / Seed / Nov 30, 2021 |
Co-Investors
About Builders VC
Builders VC is an early-stage venture capital firm focused on investing where technology meets new business models to modernize antiquated industries including healthcare, agriculture, industrials and real-estate.
Builders VC Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Amit Mehta
General Partner
|
|||
Jim Kim
Founder & General Partner
|
|||
Mark Goldstein
Partner
|
|||
Alex Kinnier
Partner
|
|||
Jocelyn Doe
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Amit Mehta invest in?
Amit Mehta invests primarily in Coffee, Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Amit Mehta last invest?
The most recent investment recorded for Amit Mehta closed in Sep 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
